Clinical Trials Logo

Chickenpox clinical trials

View clinical trials related to Chickenpox.

Filter by:

NCT ID: NCT00197015 Completed - Hepatitis A Clinical Trials

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

Start date: October 6, 2003
Phase: Phase 3
Study type: Interventional

This is a study to evaluate the immune response and safety of GSK Biologicals 2-dose inactivated hepatitis A vaccine when administered with a measles/mumps/rubella vaccine and a varicella (chickenpox) vaccine in children as young as 15 months of age. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.

NCT ID: NCT00169416 Completed - Varicella Clinical Trials

Evaluation Of Valaciclovir In Patients With Chickenpox

Start date: March 2005
Phase: Phase 3
Study type: Interventional

This study will assess the safety and efficacy, and the pharmacokinetics of aciclovir and valaciclovir in children with chickenpox following oral administration of valaciclovir, for the purpose of seeking approval of valaciclovir HCl for the treatment of chickenpox.

NCT ID: NCT00156559 Completed - Mumps Clinical Trials

MMR and Varicella Vaccine in Premature Infants

Start date: January 2004
Phase: Phase 4
Study type: Observational

This research is designed to address the question, "Does the relative deficit in vaccine immunogenicity in extremely premature infants persist beyond the first 6 months of life?" We propose to measure the immunogenicity of varicella and mumps-measles-rubella vaccines in relatively healthy, 12-to-15 month-old children born at <29 weeks gestation, when compared to full-term infants, as measured by the relevant viral serologies.

NCT ID: NCT00138255 Terminated - Measles Clinical Trials

Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines

Start date: June 2004
Phase: Phase 4
Study type: Observational

The purpose of this study is to see if the MMR and chickenpox vaccines work as well in premature infants as in children that were carried to full term. A group of children who were carried full-term will be matched for age, sex, and race and will be used for comparison.

NCT ID: NCT00127608 Completed - Varicella Clinical Trials

Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients

Start date: June 7, 2005
Phase: Phase 3
Study type: Interventional

This study is conducted in order to collect clinical samples from patients who are diagnosed of having chickenpox infection. The results of this study will provide basic scientific information about chickenpox disease.

NCT ID: NCT00127023 Completed - Measles Clinical Trials

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Start date: May 2005
Phase: Phase 3
Study type: Interventional

This is a study to evaluate the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals combined measles-mumps-rubella varicella candidate vaccine given to healthy children in their second year of life.

NCT ID: NCT00127010 Completed - Measles Clinical Trials

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Start date: November 2005
Phase: Phase 3
Study type: Interventional

This is a study to evaluate the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals combined measles-mumps-rubella varicella candidate vaccine given to healthy children in their second year of life.

NCT ID: NCT00126997 Completed - Measles Clinical Trials

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Start date: May 2005
Phase: Phase 4
Study type: Interventional

This is a study to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals live attenuated measles-mumps-rubella-varicella vaccine given to healthy children in their second year of life.

NCT ID: NCT00098046 Completed - Herpes Zoster Clinical Trials

Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection

Start date: July 2005
Phase: Phase 3
Study type: Interventional

Varicella zoster virus causes chickenpox in children and shingles in adults. Chickenpox is usually a self-limiting illness characterized by fever and a rash. Serious complications can include secondary bacterial infections, pneumonia, and encephalitis. Anti-viral treatment is not a standard of care in immunocompetent children, but is recommended whenever a risk of complication exists. This study will evaluate the safety and blood levels of a new formulation of famciclovir in children 1-12 years of age.

NCT ID: NCT00092430 Completed - Measles Clinical Trials

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Start date: September 26, 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate that an investigational refrigerated vaccine with measles, mumps, rubella, and varicella is well tolerated and has similar immune response when compared to a frozen vaccine with measles, mumps, rubella, and varicella.